{"disease":{"id":"oligodendroglial-tumor","name":"oligodendroglial tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04708548","title":"Long Term Implications of Rare Brain Tumours'","phase":"","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"Galina Velikova","has_results":false},{"nct_id":"NCT06776250","title":"Study of How Safe and Effective Tarlatamab is in Brain Cancers","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"University Health Network, Toronto","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}